2375840-87-0 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 3-chloro-5-[(2,4-difluoro-5-phenylphenyl)sulfamoyl]-4-hydroxybenzoate is utilized as a key component in the development of innovative drugs, targeting a range of medical conditions. Its unique structure and functional groups contribute to its potential therapeutic effects and pharmacological properties.
Used in Research and Development:
In the realm of scientific research, methyl 3-chloro-5-[(2,4-difluoro-5-phenylphenyl)sulfamoyl]-4-hydroxybenzoate serves as a valuable subject for exploration, enabling researchers to study its chemical behavior, interactions, and potential applications in various biological systems.
Used in Chemical Synthesis:
Methyl 3-chloro-5-[(2,4-difluoro-5-phenylphenyl)sulfamoyl]-4-hydroxybenzoate is employed as an intermediate or reactant in the synthesis of other complex organic compounds, leveraging its versatile structure and reactivity to produce a variety of chemical products.
While the provided materials do not specify distinct applications in different industries, the general uses outlined above encompass the compound's potential roles in the pharmaceutical sector, research, and chemical synthesis. Further investigation and experimentation would be necessary to determine the specific applications and reasons for using methyl 3-chloro-5-[(2,4-difluoro-5-phenylphenyl)sulfamoyl]-4-hydroxybenzoate in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 2375840-87-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,3,7,5,8,4 and 0 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 2375840-87:
(9*2)+(8*3)+(7*7)+(6*5)+(5*8)+(4*4)+(3*0)+(2*8)+(1*7)=200
200 % 10 = 0
So 2375840-87-0 is a valid CAS Registry Number.
2375840-87-0Relevant academic research and scientific papers
ACLY INHIBITORS AND USES THEREOF
-
, (2020/06/01)
The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.
